Xenpozyme 20 mg
Xenpozyme 20 mg is a medicine authorised by Swissmedic under authorisation number 67287. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 19 December 2023 and the authorisation is limited until 18 December 2028. ATC code A16AB25 places the medicine in the group Other alimentary tract and metabolism products.
| Authorisation number | 67287 |
|---|---|
| Name | Xenpozyme 20 mg |
| Full name | Xenpozyme 20 mg, poudre pour solution à diluer pour perfusion |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | A16AB25 |
| First authorisation | 19 December 2023 |
| Authorisation validity | 18 December 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Xenpozyme 20 mg, poudre pour solution à diluer pour perfusion | A | 19 December 2023 |
| 2 | Xenpozyme 4 mg, poudre pour solution à diluer pour perfusion | A | 19 December 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 1 | Durchstechflasche(n) | A16AB25 | 07.99.0. | A |
| 4 | 10 | Durchstechflasche(n) | A16AB25 | 07.99.0. | A |
| 1 | 1 | Durchstechflasche(n) | A16AB25 | 07.99.0. | A |
| 2 | 10 | Durchstechflasche(n) | A16AB25 | 07.99.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Xenpozyme 20 mg authorised in Switzerland?
Yes. Xenpozyme 20 mg is authorised by Swissmedic under authorisation number 67287, data as of 01 September 2026. The authorisation is limited until 18 December 2028.
Which dispensing category does Xenpozyme 20 mg have?
Xenpozyme 20 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Xenpozyme 20 mg?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.